Approval · Notice of Compliance 22697 · 2019
APO-MODAFINIL: Notice of Compliance 22697
Issued September 26, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22697
- Date
- September 26, 2019
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Update to product monograph
- Canadian reference product
- ALERTREC (Shire Biochem Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-MODAFINIL | Not yet assigned | — |
Medicinal ingredients
- MODAFINIL 100 MG per TAB